Russia 'expects to register second potential coronavirus vaccine by mid-October'

Russia leads the race for a coronavirus vaccine: REUTERS
Russia leads the race for a coronavirus vaccine: REUTERS

Russia is set to register a second potential vaccine against Covid-19 by October 15.

The vaccine has been developed by Siberia's Vector Institute, which completed early-stage human trials of the vaccine last week, local news has reported.

It comes after Russia registered its first vaccine candidate , developed by Moscow's Gamaleya Institute, in August.

Late-stage trials, involving at least 40,000 people, are ongoing.

Meanwhile, late-stage Indian clinical trials of Russia's potential coronavirus vaccine could take place in the next few weeks, an executive at the Indian drugmaker said on Tuesday.

The country's first vaccine is being trialled in India (REUTERS)
The country's first vaccine is being trialled in India (REUTERS)

Indian trials of the Sputnik-V vaccine candidate - being developed by Russia's sovereign wealth fund - will enroll 1,000-2,000 participants and be conducted at multiple government and private hospitals across the country, Deepak Sapra, CEO for API and pharmaceutical services at Dr Reddy's Laboratories Ltd, told Reuters.

"We want to get to the first step - which is the commencement of the clinical trials by getting the necessary approvals from the Indian regulators - within the next few weeks," Mr Sapra said.

The trials are part of a deal between the Russian Direct Investment Fund (RDIF) and Dr Reddy's, in which the Indian firm will conduct Phase III studies in India, pursue local regulatory approvals and, subject to approval, distribute the finished vaccine product in India. RDIF will supply 100 million doses to Dr Reddy's.

The RDIF has also reached agreements with Indian manufacturers to produce 300 million doses of the shot in India. Russia was the first country to grant regulatory approval for a novel coronavirus vaccine.

Russia could soon have two potential vaccines (REUTERS)
Russia could soon have two potential vaccines (REUTERS)

Sputnik-V doses supplied in India will likely be a combination of Indian- and Russian-made doses, Mr Sapra said, adding that RDIF and Dr Reddy's would soon identify potential manufacturers in India.

The RDIF has said vaccine deliveries to India could begin in late 2020, but Sapra suggested it could take longer. "I think it's going to be several months before we accomplish all the steps in the process," he added.

India, which has a population of more than 1.3 billion, is the world's second worst affected country by Covid-19 behind the United States. For weeks, it has reported the world's highest daily jump in infections, which reached a total of 5.6 million on Tuesday.

Read more

PM to address Commons with tough new 'package of measures'- LIVE

Russia slammed over poisoning of Alexei Navalny at UN clash

Novichok survivor: Russia could get away with almost anything

Russia's plan to roll-out vaccine 'could make coronavirus mutate'

Russia claims to be working on 'coronavirus vaccine for cats'

Russia is first in world to approve coronavirus vaccine, Putin claims